Citation: Sb. Gjedde et Mm. Hansen, SALVAGE THERAPY WITH FLUDARABINE IN PATIENTS WITH PROGRESSIVE B-CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 21(3-4), 1996, pp. 317-320
Authors:
BASTHOLT L
DALMARK M
GJEDDE SB
PFEIFFER P
PEDERSEN D
SANDBERG E
KJAER M
MOURIDSEN HT
ROSE C
NIELSEN OS
JAKOBSEN P
BENTZEN SM
Citation: L. Bastholt et al., DOSE-RESPONSE RELATIONSHIP OF EPIRUBICIN IN THE TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER - A RANDOMIZED STUDY OF EPIRUBICIN AT 4 DIFFERENT DOSE LEVELS PERFORMED BY THE DANISH BREAST-CANCER COOPERATIVE GROUP, Journal of clinical oncology, 14(4), 1996, pp. 1146-1155
Authors:
JAKOBSEN P
SORENSEN B
BASTHOLT L
MIRZA MR
GJEDDE SB
MOURIDSEN HT
ROSE C
Citation: P. Jakobsen et al., THE PHARMACOKINETICS OF HIGH-DOSE EPIRUBICIN AND OF THE CARDIOPROTECTOR ADR-529 GIVEN TOGETHER WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND TAMOXIFEN IN METASTATIC BREAST-CANCER PATIENTS, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 45-52
Authors:
SORENSEN B
BASTHOLT L
MIRZA MR
GJEDDE SB
JAKOBSEN P
MOURIDSEN HT
ROSE C
Citation: B. Sorensen et al., THE CARDIOPROTECTOR ADR-529 AND HIGH-DOSE EPIRUBICIN GIVEN IN COMBINATION WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND TAMOXIFEN - A PHASE-I STUDY IN METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 34(5), 1994, pp. 439-443
Authors:
PEDERSENBJERGAARD J
GJEDDE SB
PHILIP P
RORTH M
SIGSGAARD TC
NIELSEN D
HANSEN M
DOMBERNOWSKY P
LARSEN SO
Citation: J. Pedersenbjergaard et al., EPIRUBICIN AND THE RISK OF LEUKEMIA - NOT SUBSTANTIATED - REPLY, Journal of clinical oncology, 11(7), 1993, pp. 1432-1432